Literature DB >> 8083979

The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

S H Tan1, L E Leong, P A Walker, H U Bernard.   

Abstract

The E6 promoters of all genital human papillomaviruses have a characteristic alignment of transcription factor binding sites. Activation of the basic transcription complex at the TATA box depends upon a sequence-aberrant Sp1 site. Repression of E6 promoters is achieved by two binding sites for the viral E2 protein positioned between the Sp1 site and the TATA box. We have purified the human papillomavirus type 16 E2 protein after expression in Escherichia coli and studied its binding and repression properties with oligonucleotides representing the homologous promoter sequences. A Kd value of 3 x 10(-10) M indicated binding properties expected for a native protein. We found low cooperativity in the binding of two E2 dimers to flanking sites, both when these sites were separated by 3 nucleotides, as in the natural promoter, and when they were further apart. E2 protein, bound close to the distal Sp1 site, displaced the Sp1 factor even when the aberrant sequence was replaced by a typical Sp1 core recognition site. The high affinity of E2 protein for its binding site even led to Sp1 displacement at concentrations of E2 protein nearly 2 orders of magnitude lower than those of Sp1. Functional analyses of mutated E6 promoter sequences showed repression by this distal E2 binding site in the complete absence of binding to the proximal E2 binding site. From our findings and observations published by others, we conclude that each of the E2 binding sites in the E6 promoter of genital human papillomaviruses plays a separate role by displacing the transcription factors Sp1 and TFIID.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083979      PMCID: PMC237061     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target.

Authors:  R S Hegde; S R Grossman; L A Laimins; P B Sigler
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

2.  The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.

Authors:  E Ustav; M Ustav; P Szymanski; A Stenlund
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

3.  Cooperative dimerization of paired class homeo domains on DNA.

Authors:  D Wilson; G Sheng; T Lecuit; N Dostatni; C Desplan
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

4.  Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

5.  The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18.

Authors:  M Remm; R Brain; J R Jenkins
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

6.  Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 protein.

Authors:  L Sherman; N Alloul
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

7.  Cooperative DNA binding of the bovine papillomavirus E2 transcriptional activator is antagonized by truncated E2 polypeptides.

Authors:  P Monini; I L Blitz; E Cassai
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Molecular basis for specific recognition of both RNA and DNA by a zinc finger protein.

Authors:  K R Clemens; V Wolf; S J McBryant; P Zhang; X Liao; P E Wright; J M Gottesfeld
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

9.  Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses.

Authors:  S Y Chan; H U Bernard; C K Ong; S P Chan; B Hofmann; H Delius
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins.

Authors:  F Sverdrup; S A Khan
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more
  82 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Authors:  Ellora Sen; Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

4.  The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors:  M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

6.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 7.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

8.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

9.  Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy.

Authors:  S Y Chan; H Delius; A L Halpern; H U Bernard
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2.

Authors:  Matthias Ottinger; Jennifer A Smith; Michal-Ruth Schweiger; Dana Robbins; Maria L C Powell; Jianxin You; Peter M Howley
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.